LATE-NC diagnostic criteria improve differentiation from Alzheimer's, addressing challenges in memory-loss syndromes and ...

“The problem with the Alzheimer’s group is they were very co-opted,” said Peter J. Whitehouse, MD, PhD, a professor of ...

New guidelines will help doctors identify patients with a common memory-loss syndrome that is often misdiagnosed as Alzheimer's disease in older adults. The diagnostic criteria for limbic-predominant ...

Mass General Brigham “One of the main limitations in the field of Alzheimer’s disease research and treatment is that it is extremely difficult to design medications that can pass the blood ...

Jan. 22, 2025 — New guidelines will help doctors identify patients with a common memory-loss syndrome that is often misdiagnosed as Alzheimer's disease in older adults. The diagnostic criteria ...

The newly proposed criteria aim to help clinicians better differentiate LATE from Alzheimer’s, ultimately leading to more precise diagnoses and improved treatment strategies, Edelmayer noted.

In groundbreaking laboratory studies, researchers have observed remarkable improvements in mice with Alzheimer’s-like conditions after treatment with xenon gas. The process involves a carefully ...

INDICATION LEQEMBI ® [ (lecanemab-irmb) 100 mg/mL injection for intravenous use] is indicated for the treatment of Alzheimer’s disease (AD). Treatment with LEQEMBI should be initiated in patients with ...

Xenon is regularly used as an anesthesia agent. But it could also someday become an Alzheimer's treatment. © Kobus Louw via Getty The next Alzheimer’s treatment ...

New guidelines will help doctors identify patients with a common memory-loss syndrome that is often misdiagnosed as Alzheimer’s disease in older adults. The diagnostic criteria for limbic-predominant ...